OxFORD Asset Management LLP bought a new stake in Chemed Corp. (NYSE:CHE) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 4,550 shares of the company’s stock, valued at approximately $931,000.
A number of other institutional investors have also added to or reduced their stakes in CHE. BlackRock Inc. grew its position in Chemed Corp. by 145,760.9% in the first quarter. BlackRock Inc. now owns 1,955,994 shares of the company’s stock valued at $357,341,000 after purchasing an additional 1,954,653 shares in the last quarter. Vanguard Group Inc. grew its position in Chemed Corp. by 7.5% in the first quarter. Vanguard Group Inc. now owns 1,795,773 shares of the company’s stock valued at $328,070,000 after purchasing an additional 125,018 shares in the last quarter. Renaissance Technologies LLC grew its position in Chemed Corp. by 248.5% in the second quarter. Renaissance Technologies LLC now owns 70,400 shares of the company’s stock valued at $14,399,000 after purchasing an additional 50,200 shares in the last quarter. State Street Corp grew its position in Chemed Corp. by 9.1% in the first quarter. State Street Corp now owns 445,367 shares of the company’s stock valued at $81,370,000 after purchasing an additional 37,085 shares in the last quarter. Finally, AJO LP grew its position in Chemed Corp. by 49.6% in the second quarter. AJO LP now owns 94,123 shares of the company’s stock valued at $19,251,000 after purchasing an additional 31,200 shares in the last quarter. 96.96% of the stock is owned by institutional investors and hedge funds.
A number of research analysts have recently commented on the stock. BidaskClub downgraded shares of Chemed Corp. from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 22nd. Zacks Investment Research raised shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $216.00 price objective for the company in a research report on Monday, September 18th. KeyCorp assumed coverage on shares of Chemed Corp. in a research report on Monday, August 28th. They issued a “sector weight” rating for the company. Oppenheimer Holdings, Inc. lifted their price objective on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a research report on Thursday, July 27th. Finally, TheStreet downgraded shares of Chemed Corp. from a “b+” rating to a “c+” rating in a research report on Tuesday, July 25th. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $215.00.
In other news, Director Patrick P. Grace sold 500 shares of the company’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $201.48, for a total value of $100,740.00. Following the completion of the sale, the director now owns 4,515 shares in the company, valued at approximately $909,682.20. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Kevin J. Mcnamara sold 15,000 shares of the company’s stock in a transaction on Friday, July 28th. The stock was sold at an average price of $201.16, for a total transaction of $3,017,400.00. Following the completion of the sale, the insider now owns 173,801 shares of the company’s stock, valued at approximately $34,961,809.16. The disclosure for this sale can be found here. In the last quarter, insiders sold 16,500 shares of company stock valued at $3,315,600. Company insiders own 5.32% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “OxFORD Asset Management LLP Takes Position in Chemed Corp. (CHE)” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2017/10/15/oxford-asset-management-llp-takes-position-in-chemed-corp-che.html.
Chemed Corp. (CHE) opened at 199.69 on Friday. Chemed Corp. has a 12 month low of $132.92 and a 12 month high of $216.01. The stock has a 50 day moving average of $196.75 and a 200-day moving average of $197.95. The company has a market cap of $3.19 billion, a P/E ratio of 49.54 and a beta of 1.13.
Chemed Corp. (NYSE:CHE) last posted its earnings results on Tuesday, July 25th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.26. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The firm had revenue of $415.06 million during the quarter, compared to analyst estimates of $407.56 million. During the same quarter in the prior year, the business posted $1.80 EPS. The business’s revenue was up 6.3% compared to the same quarter last year. Equities research analysts expect that Chemed Corp. will post $8.21 EPS for the current year.
Chemed Corp. Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.